CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.20
-0.70 (-4.70%)
Aug 20, 2026, 4:09 PM HKT

HKG:2171 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-89.18-97.86-798.13-747.79-892.25-4,744
Depreciation & Amortization
27.7227.7277.0385.1879.9251.71
Other Amortization
1.771.772.532.221.620.74
Loss (Gain) From Sale of Assets
4.424.420.452.42-0.020.08
Asset Writedown & Restructuring Costs
--189.08-2.91-
Loss (Gain) From Sale of Investments
-----4,156
Stock-Based Compensation
25.2825.289.0914.464413.5
Other Operating Activities
-70.62-128.2457.18-22.7977.3-2.88
Change in Accounts Receivable
-6.78-6.78-8.77--2.61-6.54
Change in Inventory
-0.21-0.21-6.24-0.68--
Change in Accounts Payable
-43.04-43.0421.8116.4539.8739.93
Change in Unearned Revenue
-27.84-27.8460.89189.34-0.18-1.14
Change in Other Net Operating Assets
7.887.88-14.66.276.4-18.87
Operating Cash Flow
-170.6-236.9-409.69-454.94-643.05-512.32
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5.13-5.13-18-8.84-135.41-175.84
Sale of Property, Plant & Equipment
----0.030.01
Sale (Purchase) of Intangibles
-1-1-1.58-0.71-3.21-2.61
Investment in Securities
-0.26-0.266.75-2,443-2,316
Other Investing Activities
-1.853.525.3448.882.5822.78
Investing Cash Flow
-8.23-2.8812.5239.252,387-2,471

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--130-108.42293.22
Total Debt Issued
--130-108.42293.22
Long-Term Debt Repaid
--102.16-57.14-24.07-339.57-162.94
Total Debt Repaid
-102.16-102.16-57.14-24.07-339.57-162.94
Net Debt Issued (Repaid)
-102.16-102.1672.86-24.07-231.15130.28
Issuance of Common Stock
29.0429.041.516.6110.512,576
Repurchase of Common Stock
-115.28-115.28-50.27---
Other Financing Activities
523.7176.67-5.64-4.68-15.87-97.23
Financing Cash Flow
335.32-111.7218.46-22.14-236.512,674

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-17.48-4.148.0219.5469.32-42.07
Net Cash Flow
139-355.64-370.69-418.281,577-351.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-175.73-242.03-427.69-463.77-778.45-688.16
Free Cash Flow Growth
------
Free Cash Flow Margin
-128.63%-192.60%-1084.81%---2665.95%
Free Cash Flow Per Share
-0.33-0.44-0.77-0.83-1.41-1.78
Levered Free Cash Flow
-57.99-129.17-275.24-364.73-500.79-449.18
Unlevered Free Cash Flow
-52.97-124.86-271.67-361.82-491.09-442.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.333.335.644.6815.8710.69
Cash Income Tax Paid
--0.351.757.65-
Change in Working Capital
-70-7053.09211.3843.4813.38